Skip to search formSkip to main contentSkip to account menu

BCX4208

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Background Most gout patients treated with 300 mg/d allopurinol do not reach the therapeutic goal range serum uric acid… 
2013
2013
Background BCX4208, a novel purine nucleoside phosphorylase inhibitor, blocks uric acid production at a step preceding xanthine… 
2013
2013
Background Common comorbidities associated with gout, including obesity, hypertension, diabetes, and chronic kidney disease, may… 
2013
2013
Background BCX4208 is an oral, once-daily, purine nucleoside phosphorylase (PNP) inhibitor in clinical development as add-on…